Comparison of Percentage of Patients Achieving a Complete Response 100 Days, 6 Months, 1 Year Post Treatment [clinicaltrials_resource:ea3b8ad151f7a8baeb4915acc31e503e]
Myeloma Response Definitions - Using International Uniform Response Criteria:
Stringent Complete Response (sCR)requires, plus CR:
Normal free light chain ratio
Absence of clonal cells in bone marrow
Complete Response (CR):
Absence of the original monoclonal paraprotein
<5% plasma cells in a bone marrow aspirate and also on trephine bone biopsy
No increase in size or number of lytic bone lesions
Disappearance of soft tissue plasmacytomas.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Comparison of Percentage of Patients Achieving a Complete Response 100 Days, 6 Months, 1 Year Post Treatment [clinicaltrials_resource:ea3b8ad151f7a8baeb4915acc31e503e]
Myeloma Response Definitions - Using International Uniform Response Criteria:
Stringent Complete Response (sCR)requires, plus CR:
Normal free light chain ratio
Absence of clonal cells in bone marrow
Complete Response (CR):
Absence of the original monoclonal paraprotein
<5% plasma cells in a bone marrow aspirate and also on trephine bone biopsy
No increase in size or number of lytic bone lesions
Disappearance of soft tissue plasmacytomas.
Bio2RDF identifier
ea3b8ad151f7a8baeb4915acc31e503e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ea3b8ad151f7a8baeb4915acc31e503e
measure [clinicaltrials_vocabulary:measure]
Comparison of Percentage of Patients Achieving a Complete Response
time frame [clinicaltrials_vocabulary:time-frame]
100 Days, 6 Months, 1 Year Post Treatment
description
Myeloma Response Definitions - ...... of soft tissue plasmacytomas.
identifier
clinicaltrials_resource:ea3b8ad151f7a8baeb4915acc31e503e
title
Comparison of Percentage of Pa ...... Months, 1 Year Post Treatment
@en
type
label
Comparison of Percentage of Pa ...... b8ad151f7a8baeb4915acc31e503e]
@en